Cargando…

Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities

Somatic activating mutations in the epidermal growth factor receptor (EGFR) are one of the most common oncogenic drivers in cancers such as non-small-cell lung cancer (NSCLC), metastatic colorectal cancer, glioblastoma, head and neck cancer, pancreatic cancer, and breast cancer. Molecular-targeted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ren, Xiaoxin, Li, Yixian, Nishimura, Christopher, Zang, Xingxing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chongqing Medical University 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293717/ https://www.ncbi.nlm.nih.gov/pubmed/35873032 http://dx.doi.org/10.1016/j.gendis.2021.08.009

Ejemplares similares

The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
por: Yao, Ying, et al.
Publicado: (2023)

Key signal transduction pathways and crosstalk in cancer: Biological and therapeutic opportunities
por: Fu, Dongliao, et al.
Publicado: (2022)

Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities
por: Ge, Tongxin, et al.
Publicado: (2022)

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities
por: Rosell, Rafael, et al.
Publicado: (2021)

Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
por: Xiong, Hanchu, et al.
Publicado: (2017)

Mechanism of p38 MAPK–induced EGFR endocytosis and its crosstalk with ligand-induced pathways
por: Perez Verdaguer, Mireia, et al.
Publicado: (2021)

Monocyte:T cell interaction regulates human T cell activation through a CD28/CD46 crosstalk
por: Charron, Lauren, et al.
Publicado: (2015)

Protocol for evaluating antitumor activity of KIR3DL3 blockade in an NK cell-based xenogeneic lung tumor model
por: Ren, Xiaoxin, et al.
Publicado: (2022)

Immune Checkpoint B7x (B7-H4/B7S1/VTCN1) is Over Expressed in Spontaneous Canine Bladder Cancer: The First Report and its Implications in a Preclinical Model
por: Chand, Damini, et al.
Publicado: (2019)

Crosstalk between PRLR and EGFR/HER2 Signaling Pathways in Breast Cancer
por: Kavarthapu, Raghuveer, et al.
Publicado: (2021)

EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: La Monica, Silvia
Publicado: (2022)

EGFR transactivates RON to drive oncogenic crosstalk
por: Franco Nitta, Carolina, et al.
Publicado: (2021)

Mechanism of Dis3L2 substrate recognition in the Lin28/let-7 pathway
por: Faehnle, Christopher R., et al.
Publicado: (2014)

Two pathways of costimulation through CD28
por: Miller, Jim, et al.
Publicado: (2009)

Muscle–Bone Crosstalk: Emerging Opportunities for Novel Therapeutic Approaches to Treat Musculoskeletal Pathologies
por: Maurel, Delphine B., et al.
Publicado: (2017)

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
por: Ren, Xiaoxin, et al.
Publicado: (2022)

The LIN28/let-7 Pathway in Cancer
por: Balzeau, Julien, et al.
Publicado: (2017)

Crosstalk between the EGFR and other signalling pathways at the level of the global transcriptional corepressor Groucho/TLE
por: Hasson, P, et al.
Publicado: (2006)

The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma
por: Manier, Salomon, et al.
Publicado: (2016)

Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway
por: HUANG, LI, et al.
Publicado: (2015)

A pathway of costimulation that prevents anergy in CD28- T cells: B7- independent costimulation of CD1-restricted T cells
Publicado: (1995)

Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders
por: Vanhove, Bernard, et al.
Publicado: (2017)

Tissue-specific expression of B7x protects from CD4 T cell–mediated autoimmunity
por: Wei, Joyce, et al.
Publicado: (2011)

The Crosstalk between the EGFR and IFN-γ Pathways and Synergistic Roles in Survival Prediction and Immune Escape in Gliomas
por: Zhou, Xingang, et al.
Publicado: (2023)

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer
por: Berasain, Carmen, et al.
Publicado: (2011)

Notch-EGFR/HER2 Bidirectional Crosstalk in Breast Cancer
por: Baker, Andrew T., et al.
Publicado: (2014)

EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
por: Choudhary, Kumari Sonal, et al.
Publicado: (2016)

CD28(−) and CD28(low)CD8(+) Regulatory T Cells: Of Mice and Men
por: Vuddamalay, Yirajen, et al.
Publicado: (2017)

Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion
Publicado: (1992)

Therapeutic Opportunities with Pharmacological Inhibition of CD38 with Isatuximab
por: Martin, Thomas G., et al.
Publicado: (2019)

Aberrant RNA splicing and therapeutic opportunities in cancers
por: Yamauchi, Hirofumi, et al.
Publicado: (2021)

Potential crosstalk between cofilin-1 and EGFR pathways in cisplatin resistance of non-small-cell lung cancer
por: Müller, Carolina Beatriz, et al.
Publicado: (2015)

γδT Cells Exacerbate Podocyte Injury via the CD28/B7-1-Phosphor-SRC Kinase Pathway
por: Chen, Wanbing, et al.
Publicado: (2018)

B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling
por: Rieder, Sadiye Amcaoglu, et al.
Publicado: (2020)

Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
por: Linklater, Erik S., et al.
Publicado: (2016)

The PD-1/PD-L1 (B7-H1) Pathway in Chronic Infection-Induced Cytotoxic T Lymphocyte Exhaustion
por: Hofmeyer, Kimberly A., et al.
Publicado: (2011)

CDK4/6 and MAPK—Crosstalk as Opportunity for Cancer Treatment
por: Scheiblecker, Lisa, et al.
Publicado: (2020)

Upregulation of the B7/CD28 family member B7-H3 in bladder cancer
por: WU, DEYAO, et al.
Publicado: (2015)

The role of p21ras in CD28 signal transduction: triggering of CD28 with antibodies, but not the ligand B7-1, activates p21ras
Publicado: (1994)

Crosstalk Between Apoptosis and Autophagy: Molecular Mechanisms and Therapeutic Strategies in Cancer
por: El-Khattouti, Abdelouahid, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8i4vjobr1299hh2t4v9m6rd0t6